Question 1

What are the potential risks and benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor clinical trial (NCT00404768). Contact the study team or your healthcare provider for specific answers.

Question 2

How does GSK221149A compare to other treatments for pre-term labor?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor clinical trial (NCT00404768). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment process look like, and how long will it take?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor clinical trial (NCT00404768). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor clinical trial (NCT00404768). Contact the study team or your healthcare provider for specific answers.

Question 5

Will I need to travel for visits, and how often?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor clinical trial (NCT00404768). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor clinical trial (NCT00404768). Contact the study team or your healthcare provider for specific answers.

What this study is about